Clinical Laserthermia Systems Future Growth
Future criteria checks 2/6
Clinical Laserthermia Systems is forecast to grow earnings and revenue by 63.8% and 51.9% per annum respectively.
Key information
63.8%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 51.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 02 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 64 | N/A | N/A | -9 | 1 |
| 12/31/2025 | 43 | -25 | -24 | -20 | 1 |
| 12/31/2024 | 23 | -51 | -61 | -56 | 1 |
| 9/30/2024 | 19 | -64 | -65 | -59 | N/A |
| 6/30/2024 | 15 | -68 | -63 | -59 | N/A |
| 3/31/2024 | 11 | -71 | -75 | -72 | N/A |
| 12/31/2023 | 8 | -80 | -72 | -66 | N/A |
| 9/30/2023 | 8 | -63 | -74 | -70 | N/A |
| 6/30/2023 | 7 | -77 | -81 | -78 | N/A |
| 3/31/2023 | 6 | -78 | -85 | -82 | N/A |
| 12/31/2022 | 6 | -71 | -82 | -82 | N/A |
| 9/30/2022 | 3 | -81 | -81 | -81 | N/A |
| 6/30/2022 | 2 | -63 | -66 | -66 | N/A |
| 3/31/2022 | 2 | -68 | -71 | -71 | N/A |
| 12/31/2021 | 2 | -64 | -67 | -66 | N/A |
| 9/30/2021 | 1 | -60 | -63 | -63 | N/A |
| 6/30/2021 | 2 | -57 | -55 | -55 | N/A |
| 3/31/2021 | 2 | -47 | -41 | -41 | N/A |
| 12/31/2020 | 1 | -58 | -56 | -55 | N/A |
| 9/30/2020 | 1 | -58 | -54 | -53 | N/A |
| 6/30/2020 | 2 | -57 | -54 | -54 | N/A |
| 3/31/2020 | 6 | -54 | -52 | -52 | N/A |
| 12/31/2019 | 6 | -43 | -39 | -39 | N/A |
| 9/30/2019 | 6 | -38 | -37 | -36 | N/A |
| 6/30/2019 | 5 | -37 | -35 | -34 | N/A |
| 3/31/2019 | 1 | -41 | -44 | -43 | N/A |
| 12/31/2018 | 8 | -33 | -41 | -39 | N/A |
| 9/30/2018 | 10 | -28 | -33 | -31 | N/A |
| 6/30/2018 | 11 | -24 | N/A | -31 | N/A |
| 3/31/2018 | 12 | -15 | N/A | -24 | N/A |
| 12/31/2017 | 8 | -21 | N/A | -24 | N/A |
| 9/30/2017 | 8 | -22 | N/A | -29 | N/A |
| 6/30/2017 | 8 | -26 | N/A | -24 | N/A |
| 3/31/2017 | 6 | -27 | N/A | -23 | N/A |
| 12/31/2016 | 4 | -27 | N/A | -20 | N/A |
| 9/30/2016 | 1 | -27 | N/A | -19 | N/A |
| 6/30/2016 | 0 | -23 | N/A | -22 | N/A |
| 3/31/2016 | 0 | -20 | N/A | -17 | N/A |
| 12/31/2015 | N/A | -17 | N/A | -19 | N/A |
| 9/30/2015 | 0 | -21 | N/A | -21 | N/A |
| 6/30/2015 | 0 | -20 | N/A | -20 | N/A |
| 3/31/2015 | 0 | -20 | N/A | -19 | N/A |
| 12/31/2014 | N/A | -18 | N/A | -16 | N/A |
| 9/30/2014 | 0 | -16 | N/A | -18 | N/A |
| 6/30/2014 | N/A | -16 | N/A | -18 | N/A |
| 3/31/2014 | N/A | -17 | N/A | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LS60 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LS60 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LS60 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LS60's revenue (51.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: LS60's revenue (51.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LS60's Return on Equity is forecast to be high in 3 years time